Evidence map›Paper›PMID 42409969›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2026

"Right baby, right time: a multi-NICU quality improvement initiative using the 2022 NICHD BPD risk estimator to guide timely steroid therapy".

A Martinez, A Germain, O Winners, F Shakeel, K Makker, S Desiraju, M M Gilmore, M Gontasz, S Atteih, J Fierstein and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

A MartinezMaternal, Fetal & Neonatal Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
A GermainMaternal, Fetal & Neonatal Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.ORCID http://orcid.org/0009-0006-4228-092X
O WinnersMaternal, Fetal & Neonatal Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
F ShakeelMaternal, Fetal & Neonatal Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
K MakkerDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Baltimore, MD, USA.
S DesirajuDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Baltimore, MD, USA.
M M GilmoreDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2611-0606
M GontaszDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Baltimore, MD, USA.
S AtteihDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Baltimore, MD, USA.
J FiersteinEpidemiology and Biostatistics Shared Resource, Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
J MachryMaternal, Fetal & Neonatal Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA. jmachry1@jhmi.edu.ORCID http://orcid.org/0009-0001-0903-6822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveUsing the 2022 NICHD BPD risk estimator (BPDe2022) to improve timely identification of extremely preterm neonates at risk for bronchopulmonary dysplasia (BPD) and to optimize appropriate systemic corticosteroid (SC) therapy. STUDY

designQuality Improvement initiative across three NICUs within Johns Hopkins Health System. Plan-Do-Study-Act (PDSA) cycles focused on EMR integration, documentation, and provider education on risk estimation and SC use. Included neonates born ≤28 6/7 weeks GA or ≤1000 g BW. Outcome, process, and balancing measures were tracked from April 2024 through April 2025.

resultsBPD risk assessment documentation increased from 2% to 80%, and appropriate SC prescribing from 50% to 88%, temporally associated with intervention implementation. Mortality before 36 weeks PMA decreased from 19% to 4% (p < 0.001).

conclusionMulti-NICU QI initiative successfully integrated the 2022 NICHD BPD risk estimator into clinical workflows, improving timely risk assessment and adherence to evidence-based corticosteroid prescribing and stewardship.

Identifiers

PMID42409969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.